Literature DB >> 30838309

Apomorphine, More Evidence for An Old Drug: A Key for Therapy Generalization?

Lucia Ameghino1, Malco Rossi1.   

Abstract

Entities:  

Keywords:  Parkinson's disease; apomorphine; apomorphine subcutaneous infusion; dopamine agonist

Year:  2019        PMID： 30838309      PMCID： PMC6384177          DOI： 10.1002/mdc3.12717

Source DB:  PubMed          Journal:  Mov Disord Clin Pract        ISSN： 2330-1619


× No keyword cloud information.
  5 in total

1.  Levodopa and the progression of Parkinson's disease.

Authors:  Stanley Fahn; David Oakes; Ira Shoulson; Karl Kieburtz; Alice Rudolph; Anthony Lang; C Warren Olanow; Caroline Tanner; Kenneth Marek
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

2.  Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial.

Authors:  Regina Katzenschlager; Werner Poewe; Olivier Rascol; Claudia Trenkwalder; Günther Deuschl; K Ray Chaudhuri; Tove Henriksen; Teus van Laar; Kevin Spivey; Senthil Vel; Harry Staines; Andrew Lees
Journal:  Lancet Neurol       Date:  2018-07-25       Impact factor: 44.182

3.  EuroInf: a multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease.

Authors:  Pablo Martinez-Martin; Prashanth Reddy; Regina Katzenschlager; Angelo Antonini; Antoniya Todorova; Per Odin; Tove Henriksen; Anne Martin; Daniela Calandrella; Alexandra Rizos; Narissah Bryndum; Arne Glad; Haidar Salimi Dafsari; Lars Timmermann; Georg Ebersbach; Milica G Kramberger; Michael Samuel; Karoline Wenzel; Volker Tomantschger; Alexander Storch; Heinz Reichmann; Zvezdan Pirtosek; Maja Trost; Per Svenningsson; Sven Palhagen; Jens Volkmann; K Ray Chaudhuri
Journal:  Mov Disord       Date:  2014-11-10       Impact factor: 10.338

4.  Apomorphine infusion in advanced Parkinson's patients with subthalamic stimulation contraindications.

Authors:  Sophie Drapier; Anne-Sophie Gillioz; Emmanuelle Leray; Julie Péron; Tiphaine Rouaud; Annaig Marchand; Marc Vérin
Journal:  Parkinsonism Relat Disord       Date:  2011-09-03       Impact factor: 4.891

5.  Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: concept and standards of the EARLYSTIM-study.

Authors:  Günther Deuschl; Michael Schüpbach; Karina Knudsen; Marcus O Pinsker; Philippe Cornu; Jörn Rau; Yves Agid; Carmen Schade-Brittinger
Journal:  Parkinsonism Relat Disord       Date:  2012-07-28       Impact factor: 4.891
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.